Literature DB >> 20070155

DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.

Raju K Mandal1, Ruchika Gangwar, Anil Mandhani, Rama Devi Mittal.   

Abstract

Interindividual variation in prostate cancer (PCa) susceptibility may be modulated in part through genetic polymorphisms in the DNA repair genes, especially the genes involved in the base excision repair and nucleotide excision repair pathway. Two of the common single-nucleotide polymorphisms X-ray repair cross-complementing group 1 (XRCC1) and Xeroderma pigmentosum group D (XPD) genes in PCa, which is one of the most common neoplasias in men all over the world, have been studied. In a case-control study of 171 PCa patients and 200 age-matched healthy controls, of similar ethnicity, genotyping was done to determine XPD exon 10 (G23592A), exon 23 (A35931C), and XRCC1 exon 6 (C26304T), exon 9 (G27466A), exon 10 (G23591A) gene polymorphisms by amplification refractory mutation-specific and polymerase chain reaction-restriction fragment length polymorphism methods, respectively. We observed that XPD exon 10 variant AA genotype was associated with increased risk for PCa (adjusted odds ratio [OR] 2.63, 95% confidence interval [95% CI] 1.40-4.92, p = 0.003), and XRCC1 exon 9 GA genotype was also statistically associated with PCa (adjusted OR 2.61, 95% CI 1.53-4.43, p < 0.001). However, XPD exon 23 (A>C) and XRCC1 exon 6 (C>T) and exon 10 (G>A) did not have significantly increased risk for PCa. The haplotype analysis of XPD exon 10 and exon 23 G-C (OR 3.44, 95% CI 2.15-5.51, p < 0.0001) and A-A (OR 4.96, 95% CI 3.08-7.98, p < 0.0001) was associated with a significant increase in PCa risk. Similarly, the combined analysis of XRCC1 exon 6, exon 9, and exon 10 C-G-A (OR 2.93, 95% CI 1.91-4.50, p < 0.001) and C-A-G (OR 2.48, 95% CI 1.62-3.80, p < 0.001) demonstrated statistically significant risk in PCa. XRCC1 exon 9 GA genotype showed protective association with high grade of PCa. Our results suggest a positive association of XRCC1 exon 9 and XPD exon 10 genotypes that may play an important role in the pathophysiology and may modulate the risk of PCa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20070155     DOI: 10.1089/dna.2009.0956

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  11 in total

1.  XPD Asp312Asn polymorphism is a risk factor for prostate cancer.

Authors:  Shao-Guang Liao; Lu Liu; Ying Wang; Ying-Yi Zhang; Ya-Jie Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-29       Impact factor: 4.553

2.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

3.  Murine Prkdc polymorphisms impact DNA-PKcs function.

Authors:  Kristin M Fabre; Lila Ramaiah; Ryan C Dregalla; Christian Desaintes; Michael M Weil; Susan M Bailey; Robert L Ullrich
Journal:  Radiat Res       Date:  2011-01-25       Impact factor: 2.841

4.  Meta-analysis on the association of nucleotide excision repair gene XPD A751C variant and cancer susceptibility among Indian population.

Authors:  Raju Kumar Mandal; Suraj Singh Yadav; Aditya K Panda
Journal:  Mol Biol Rep       Date:  2013-12-22       Impact factor: 2.316

5.  Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and prostate cancer risk.

Authors:  Feng He; Guizhong Li; Libo Man; Ning Liu
Journal:  Tumour Biol       Date:  2014-02-04

6.  Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.

Authors:  Yuanyuan Mi; Lifeng Zhang; Ninghan Feng; Sheng Wu; Xiaoming You; Hongbao Shao; Feng Dai; Tao Peng; Feng Qin; Jiangang Zou; Lijie Zhu
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

7.  Meta-Analysis of the Relationship between XRCC1-Arg399Gln and Arg280His Polymorphisms and the Risk of Prostate Cancer.

Authors:  Jie Yan; Xiantao Wang; Hui Tao; Zengfu Deng; Wang Yang; Faquan Lin
Journal:  Sci Rep       Date:  2015-04-30       Impact factor: 4.379

8.  Association between codon 399 polymorphism in the X-ray repair cross-complementing group 1 gene and risk of prostate cancer in Asians: A study of 4,479 cases and 4,281 controls.

Authors:  Mi Yuanyuan; You Xiaoming; Zhu Lijie; Feng Ninghan
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

9.  Association Between the Asp312Asn, Lys751Gln, and Arg156Arg Polymorphisms in XPD and the Risk of Prostate Cancer.

Authors:  Weijin Fu; Feifan Xiao; Ruoheng Zhang; Jiatong Li; Dong Zhao; Xuandong Lin; Yanzhen Xu; Xiaowei Song; Zhibin Xie; Qiongxian Wen; Xiaoli Yang
Journal:  Technol Cancer Res Treat       Date:  2017-08-11

Review 10.  Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.

Authors:  Feifan Xiao; Jian Pu; Qiongxian Wen; Qin Huang; Qinle Zhang; Birong Huang; Shanshan Huang; Aihua Lan; Yuening Zhang; Jiatong Li; Dong Zhao; Jing Shen; Huayu Wu; Yan He; Hongtao Li; Xiaoli Yang
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.